ACCUVEIN INC.

ACCUVEIN INC. specializes in the design, manufacturing, and delivery of advanced vein visualization systems for clinical use in healthcare settings. Their core capability centers on infrared-based medical imaging technology that enhances venous access accuracy, particularly for peripheral intravenous catheter insertion. The company’s products, including the ACCUVEIN AV500 and related vein finder systems, serve as critical adjunct tools for nurses and clinicians, reducing failed insertions, minimizing patient trauma, and improving procedural efficiency in high-volume environments. Technical expertise includes optical imaging hardware integration, real-time tissue contrast enhancement, and FDA-cleared medical device development aligned with ISO 13485 quality standards. Their solutions are engineered for bedside deployment, emphasizing ergonomic design, intuitive user interfaces, and compatibility with standard clinical workflows. The company maintains a consistent presence with the Department of Veterans Affairs, where its systems are procured to support veteran care delivery across VA medical centers, particularly in emergency, critical care, and outpatient infusion settings. The Department of Health and Human Services also relies on ACCUVEIN’s technology for clinical standardization initiatives, especially in facilities implementing evidence-based practices for vascular access. These agencies consistently procure the same product lines, indicating long-term adoption and trust in the platform’s reliability. ACCUVEIN INC. operates exclusively within the surgical and medical instrument manufacturing sector (NAICS 339112), positioning itself as a niche provider of diagnostic-assist medical devices focused on vascular access. The company’s market differentiation lies in its proprietary vein imaging technology, which fills a critical gap in procedural safety and efficiency for frontline healthcare workers. As a small business structured as a 2L entity based in Medford, NY, ACCUVEIN INC. has no federal certifications on record. Its geographic footprint is centered on federal procurement channels, with all known activity tied to U.S. government healthcare systems. The company’s business model reflects a focused, product-driven approach to serving public health infrastructure through clinically validated medical devices.